Press Releases

Press Releases

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that it has completed enrollment in the post-marketing pediatric clinical trial that is expected to…

Press Releases

Xcovery, a developer of targeted therapeutics for cancer, today announced the initiation of its Phase 3 trial of X-396 in patients with anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC). The eXalt3 trial is an open-label, randomized study designed to evaluate the efficacy and safety of X-396, the…

Press Releases

Cascadian Therapeutics (CASC), a clinical-stage biopharmaceutical company, today announced that the ONT-380 program in advanced HER2+ metastatic breast cancer has received Fast Track designation from the U.S. Food and Drug Administration ("FDA"). The Company is actively recruiting patients for a randomized, double-blind, placebo-controlled Phase 2 study, known as HER2CLIMB, evaluating…

Press Releases

Join us for this highly anticipated 8th Annual Next Generation Sequencing Congress and 4th Annual Single Cell Analysis Congress, 10-11 November 2016 in London to discover what opportunities lie in the industry for your business by networking with internationally acknowledged VPs, Directors, Heads and other senior level experts. Co-located with…

Press Releases

Kiadis Pharma N.V., a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders, announces that at its Annual General Meeting held today at 10:00 CEST at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands, all resolutions were duly passed…

Press Releases

Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s new drug applications (NDAs) for two products for adolescent and adult patients with asthma. The first, fluticasone propionate/salmeterol, is a fixed-dose combination inhaled corticosteroid (ICS) and long-acting beta agonist (LABA) delivered…

Press Releases

Moberg Pharma AB (OMX:MOB) today announced that its partner, Menarini Asia-Pacific, recently initiated the launch of Emtrix® in Japan and that the initial consumer response has been strong. In the U.S., Kerasal Nail® has further increased its market share following the recent repositioning of the brand. The roll-out of the…

Press Releases

Join us for this highly anticipated 2nd Annual Genome Editing Congress, 10-11 November 2016 in London to discover what opportunities lie in the industry for your business by networking with internationally acknowledged VPs, Directors, Heads and other senior level experts. Co-located with the highly established 8th Annual Next Generation Sequencing…

Press Releases

Pulmatrix, Inc., a pharmaceutical company developing innovative inhaled drugs today announced the release of an animated life sciences video [ir.pulmatrix.com] to raise awareness of the problem of serious lung diseases and to describe promising new treatments. "Millions of people struggle to breathe every day because of such diseases as chronic…

Press Releases

Icagen, Inc. has announced today a definitive agreement to acquire Sanofi's ultra high-throughput biology, screening and chemistry capabilities and research facility in Oro Valley, Arizona (located near Tucson Arizona), to collaborate in a multi-year services contract for long term discovery services.  Icagen will retain the majority of the talented scientists…